Nektar Therapeutics (NKTR)
86.46
+1.42
(+1.67%)
USD |
NASDAQ |
May 01, 16:00
86.55
+0.09
(+0.10%)
After-Hours: 20:00
Nektar Therapeutics EPS Diluted (Quarterly) : -1.778 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.897 |
| Eli Lilly & Co. | 8.255 |
| Soleno Therapeutics, Inc. | 0.7904 |
| Aquestive Therapeutics, Inc. | -0.2612 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.08M |
| Revenue (Quarterly) | 21.81M |
| Total Expenses (Quarterly) | 57.89M |
| Enterprise Value | 1.399B |
| Gross Profit Margin (Quarterly) | 99.13% |
| Profit Margin (Quarterly) | -165.4% |
| Earnings Yield | -7.92% |
| Normalized Earnings Yield | -7.544 |